DNAlytics

Chemin Du Cyclotron 6

1348 Ottignies-Louvain-La-Neuve

BE

DNAlytics

Foundation date

03/04/2012

Sector

#Biotechnology / R&D Services

Subsector

DNAlytics bases its activity on a Data Mining platform that it applies to develop personalized medicine solutions, from R&D to market access: diagnostic, prognostic and treatment response prediction, coupled with biomarker identification. DNAlytics has two main offers based on this technology platform: an expert consulting activity for pharmaceutical, biotech or IVD companies, and a product pipeline development. Its 1st product is RheumaKit, an early diagnostic solution for undifferentiated arthritis.

Upcoming events

Latest news

  • UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa

    1 day ago

  • Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity

    Tuesday December 6th 2022

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022